Trade Summary

3 days ago, GOLDSMITH MARK A, serving as See Remarks at Revolution Medicines, Inc. (RVMD), sold 10,020 shares at $156.12 per share, for a total transaction value of $1,564,310.38. Following this transaction, GOLDSMITH MARK A now holds 267,330 shares of RVMD.

This sale represents a 3.61% decrease in GOLDSMITH MARK A's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, June 16, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 18, 2026 at 4:11 PM ET, 2 days after the trade was made.

Revolution Medicines, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.